A private equity firm located in the US Southeast has $1 billion in assets under management. The firm is interested in companies located all over the globe and makes 1-3 equity investments per year into commercial stage, revenue generating companies. The firm will lead a round if it is less than $20m but – if larger, co-invests alongside other private equity firms that it has relationships with. The minimum investment size is $1 million.
The firm is interested in therapeutics, medical devices, R&D services, and suppliers & engineering. The firm is particularly interested in over-the-counter and consumer health products and is otherwise open to all indication areas. Within medtech, the firm looks for products that have already received regulatory approval. Within therapeutics, the firm will consider Phase 3 or later. Orphan diseases are of interest as well.
The firm has no fixed management team requirements and takes a board seat on all investments.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com
Next Phase Newsletter 
Leave a comment